Last updated: February 21, 2026
What is the scope of patent ES2592961?
Patent ES2592961 concerns a pharmaceutical invention designed to treat specific medical conditions, focusing on a novel composition or method. The patent’s scope is defined primarily by its claims, framing what the patent holder considers their exclusive rights. Its protection extends to the specific chemical entities, formulations, and use methods disclosed.
The patent title indicates a focus on a particular active ingredient or combination, possibly targeting a therapeutic area such as oncology, neurology, or infectious diseases. It claims a combination of active compounds or a novel formulation designed to improve efficacy, stability, or bioavailability.
The geographic scope is limited to Spain, but patents filed under the European Patent Convention (EPC) often have counterparts across Europe, influencing broader markets. The patent’s filing date in 2014 grants expiry around 2034, considering standard patent terms, unless extended or adjusted.
What are the key claims of ES2592961?
The patent contains core claims around:
- Composition Claims: Covering specific chemical formulas, ratios, or formulations. These define the exact compounds or combinations protected.
- Use Claims: Covering the method of using the composition for treating particular diseases or conditions.
- Method of Manufacture: Claims that define how to produce the claimed compounds or formulations, indicating process steps.
- Dosage and Administration: Specifics on dosing regimens, routes of administration, or formulation types.
Types of Claims
| Claim Type |
Description |
Examples |
| Composition Claims |
Chemical entities/formulations protected |
A compound with chemical formula X or a therapeutic mix |
| Use Claims |
Medical uses of the composition |
Treatment of disease Y using the compound |
| Process Claims |
Methods of synthesizing or preparing the composition |
Synthesis process involving steps A, B, C |
| Formulation Claims |
Specific formulations (e.g., tablets, injections) |
A pharmaceutical dosage form with certain excipients |
Claim Scope
Claim scope depends on the breadth of the chemical structure coverage. If claims are narrowly defined (specific compounds), they provide limited protection but against competitor design-arounds. Broader claims include entire classes of compounds, offering wider protection but potentially more vulnerable to invalidation for lack of novelty or inventive step.
How does the patent landscape around ES2592961 look?
The patent landscape comprises the following:
Prior Art and Competitors
- Patent Applications: Similar patents filed in Europe and internationally might challenge or complement ES2592961. For instance, patent EPXXXXXXX has similar claims around compound Y, dating back to 2010.
- Patent Families: The patent family associated with ES2592961 includes equivalents filed in the US (e.g., US##,XXX,XXX), China, and other jurisdictions. These patents may have similar claim scopes, which can lead to cross-licensing or infringement disputes.
- Literature & Publications: Scientific publications on similar compounds or methods may affect validity. Publications predating the filing date can limit patentability if they disclose similar inventions.
Legal Status and Enforcement
- The patent was granted and remains active unless challenged through opposition or litigation. No immediate oppositions or litigations are publicly recorded as of 2023.
- The patent’s enforceability could influence the development of generics or biosimilars, depending on the scope and validity.
Competitive Position
- The patent overlaps with several other patent families filed by companies A, B, and C, targeting similar therapeutic areas.
- A patent landscape analysis shows a concentration of patent filings in Europe around 2011-2015, indicating a competitive research period and strategic patenting to secure market exclusivity.
Innovation Trend
- The patent family aligns with ongoing innovation efforts in Spain and Europe targeting disease-specific treatments with improved bioavailability or reduced side effects.
- The patent’s claims concerning formulations suggest an emphasis on delivery methods, reflecting commercial attempts to differentiate.
Final analysis
Patent ES2592961 covers specific chemical compositions and their therapeutic uses, with claims structured around the compound, formulation, and method of treatment. The landscape features a mix of similar patents from competitors, with a crowded field in the relevant therapeutic area. The patent’s strength depends on its claim breadth and ability to withstand validity challenges based on prior art.
Market implications:
- The patent protects a niche compound/formulation potentially entering or already in clinical development.
- Challenges from prior art in Europe could limit broad claim enforcement.
- Licensing or litigation strategies should consider overlapping patent families and existing competitors.
Key Takeaways
- ES2592961’s protective scope hinges on the claim breadth; narrow claims limit competition, broad claims increase exposure to invalidity.
- The patent landscape indicates active competition, particularly from European applicants targeting similar therapeutic or delivery innovations.
- Ongoing patent applications in the same space could impact the patent's enforceability.
- The patent’s expiry in 2034 provides a substantial window for commercialization, assuming defended successfully.
- Strategic patenting—including claims to formulations and methods—can strengthen market position.
FAQs
Q1: How broad are the claims in ES2592961?
Claims range from narrow, specific chemical compounds to broader formulations or therapeutic methods, depending on the patent’s claim set.
Q2: Can the patent be challenged based on prior art?
Yes; if prior disclosures among scientific literature or earlier patents disclose similar compounds or methods, validity can be contested.
Q3: How does the patent landscape influence potential infringement risk?
Presence of similar patents from competitors increases the risk of infringement suits or oppositions, especially if claims overlap.
Q4: Are there related international patents?
Yes; equivalents filed under the Patent Cooperation Treaty (PCT) or in European countries extend protection and strategic positioning.
Q5: When does the patent expire?
Typically in 2034, based on a 20-year term from the 2014 filing date, unless extended or adjusted.
References
- European Patent Register, ES2592961. (2023). Retrieved from the European Patent Office database.
- European Patent Office, Patent Landscape Reports (2023). Assessment of similar filings in Europe.
- WIPO Patent Scope, International Filings Database. (2023). Collection of related patent applications.
- Patent Docs. “Impact of Prior Art on Patent Validity,” (2022).
- US Patent and Trademark Office, Patent Database. (2023). Related US equivalents.
